Livzon Pharmaceutical Group Inc Asset Resilience Ratio

Latest as of March 2026: 2.93%

Livzon Pharmaceutical Group Inc asset resilience ratio. Livzon Pharmaceutical Group Inc (000513) has an Asset Resilience Ratio of 2.93% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Livzon Pharmaceutical Group Inc (000513) financial obligations for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥707.99 Million
≈ $103.60 Million USD Cash + Short-term Investments

Total Assets

CN¥24.19 Billion
≈ $3.54 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of Livzon Pharmaceutical Group Inc (1994–2025)

Asset resilience ratio of Livzon Pharmaceutical Group Inc from 1994 to 2025. This chart shows how Livzon Pharmaceutical Group Inc's Asset Resilience Ratio has changed over time. See Livzon Pharmaceutical Group Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Liquid Assets Composition Over Time

This chart breaks down Livzon Pharmaceutical Group Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 000513 total asset value.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥707.99 Million 2.93%
Total Liquid Assets CN¥707.99 Million 2.93%

Asset Resilience Insights

  • Limited Liquidity: Livzon Pharmaceutical Group Inc maintains only 2.93% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Livzon Pharmaceutical Group Inc Industry Peers by Asset Resilience Ratio

Compare Livzon Pharmaceutical Group Inc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Takeda Pharmaceutical Company Limited
F:TKDA
Drug Manufacturers - Specialty & Generic 0.69%
Galderma Group N
SW:GALD
Drug Manufacturers - Specialty & Generic 3.56%
Enzymatica publ AB
ST:ENZY
Drug Manufacturers - Specialty & Generic 22.17%
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
Drug Manufacturers - Specialty & Generic 9.04%
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566
Drug Manufacturers - Specialty & Generic 47.16%
Kangmei Pharmaceutical Co Ltd
SHG:600518
Drug Manufacturers - Specialty & Generic 0.00%
Walvax BioTech
SHE:300142
Drug Manufacturers - Specialty & Generic 2.20%
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858
Drug Manufacturers - Specialty & Generic 3.47%

Livzon Pharmaceutical Group Inc Asset Resilience Ratio by Year (1994–2025)

Livzon Pharmaceutical Group Inc asset resilience ratio by year from 1994 to 2025. The table below shows the annual Asset Resilience Ratio data for Livzon Pharmaceutical Group Inc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 6.73% CN¥1.62 Billion
≈ $236.36 Million
CN¥23.99 Billion
≈ $3.51 Billion
+6.37pp
2024-12-31 0.37% CN¥89.36 Million
≈ $13.08 Million
CN¥24.46 Billion
≈ $3.58 Billion
+0.04pp
2023-12-31 0.33% CN¥81.79 Million
≈ $11.97 Million
CN¥25.04 Billion
≈ $3.66 Billion
-0.11pp
2022-12-31 0.43% CN¥108.09 Million
≈ $15.82 Million
CN¥24.87 Billion
≈ $3.64 Billion
-0.38pp
2021-12-31 0.82% CN¥182.77 Million
≈ $26.75 Million
CN¥22.37 Billion
≈ $3.27 Billion
+0.69pp
2020-12-31 0.13% CN¥25.98 Million
≈ $3.80 Million
CN¥20.59 Billion
≈ $3.01 Billion
+0.03pp
2019-12-31 0.10% CN¥17.19 Million
≈ $2.52 Million
CN¥17.98 Billion
≈ $2.63 Billion
+0.00pp
2018-12-31 0.09% CN¥15.93 Million
≈ $2.33 Million
CN¥17.44 Billion
≈ $2.55 Billion
-0.03pp
2017-12-31 0.12% CN¥18.60 Million
≈ $2.72 Million
CN¥15.90 Billion
≈ $2.33 Billion
+0.06pp
2016-12-31 0.06% CN¥6.02 Million
≈ $880.78K
CN¥10.53 Billion
≈ $1.54 Billion
-0.02pp
2015-12-31 0.08% CN¥6.59 Million
≈ $964.21K
CN¥8.08 Billion
≈ $1.18 Billion
-0.01pp
2014-12-31 0.09% CN¥6.42 Million
≈ $939.97K
CN¥7.30 Billion
≈ $1.07 Billion
-0.08pp
2013-12-31 0.17% CN¥11.34 Million
≈ $1.66 Million
CN¥6.57 Billion
≈ $960.81 Million
-0.88pp
2012-12-31 1.05% CN¥59.32 Million
≈ $8.68 Million
CN¥5.63 Billion
≈ $824.40 Million
+0.09pp
2011-12-31 0.96% CN¥44.34 Million
≈ $6.49 Million
CN¥4.60 Billion
≈ $673.55 Million
-0.62pp
2010-12-31 1.58% CN¥57.87 Million
≈ $8.47 Million
CN¥3.66 Billion
≈ $535.86 Million
+0.02pp
2009-12-31 1.56% CN¥48.89 Million
≈ $7.15 Million
CN¥3.12 Billion
≈ $457.19 Million
-2.60pp
2008-12-31 4.17% CN¥121.78 Million
≈ $17.82 Million
CN¥2.92 Billion
≈ $427.85 Million
-11.05pp
2007-12-31 15.21% CN¥448.10 Million
≈ $65.57 Million
CN¥2.95 Billion
≈ $431.05 Million
+8.52pp
2006-12-31 6.69% CN¥168.34 Million
≈ $24.63 Million
CN¥2.52 Billion
≈ $368.05 Million
+3.43pp
2005-12-31 3.26% CN¥70.50 Million
≈ $10.32 Million
CN¥2.16 Billion
≈ $316.61 Million
-1.97pp
2004-12-31 5.23% CN¥115.11 Million
≈ $16.84 Million
CN¥2.20 Billion
≈ $322.21 Million
+2.39pp
2003-12-31 2.84% CN¥60.46 Million
≈ $8.85 Million
CN¥2.13 Billion
≈ $311.58 Million
+1.93pp
2002-12-31 0.91% CN¥16.88 Million
≈ $2.47 Million
CN¥1.86 Billion
≈ $271.77 Million
-0.05pp
2001-12-31 0.95% CN¥15.96 Million
≈ $2.33 Million
CN¥1.67 Billion
≈ $244.65 Million
+0.26pp
2000-12-31 0.69% CN¥10.70 Million
≈ $1.57 Million
CN¥1.55 Billion
≈ $226.56 Million
+0.59pp
1996-12-31 0.10% CN¥1.30 Million
≈ $190.33K
CN¥1.32 Billion
≈ $192.68 Million
-0.41pp
1995-12-31 0.51% CN¥5.67 Million
≈ $830.39K
CN¥1.11 Billion
≈ $162.40 Million
-0.77pp
1994-12-31 1.28% CN¥11.18 Million
≈ $1.64 Million
CN¥870.12 Million
≈ $127.33 Million
--
pp = percentage points

About Livzon Pharmaceutical Group Inc

SHE:000513 China Drug Manufacturers - Specialty & Generic
Market Cap
$2.45 Billion
CN¥16.77 Billion CNY
Market Cap Rank
#5286 Global
#861 in China
Share Price
CN¥28.52
Change (1 day)
+3.18%
52-Week Range
CN¥25.97 - CN¥37.60
All Time High
CN¥1418.81
About

Livzon Pharmaceutical Group Inc. researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients (API) and intermediates in the People's Republic of China and internationally. The company offers leuprorelin acetate microspheres, urofollitropin, and menotropins for injection for the assisted reproduction field; Ilaprazole enteric-coated tablets, il… Read more